A detailed history of Janus Henderson Group PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 10,047,026 shares of ABBV stock, worth $1.79 Billion. This represents 1.06% of its overall portfolio holdings.

Number of Shares
10,047,026
Previous 11,450,623 12.26%
Holding current value
$1.79 Billion
Previous $1.96 Billion 1.02%
% of portfolio
1.06%
Previous 1.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $230 Million - $280 Million
-1,403,597 Reduced 12.26%
10,047,026 $1.98 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $85.5 Million - $99.8 Million
552,377 Added 5.07%
11,450,623 $1.96 Billion
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $198 Million - $226 Million
1,240,434 Added 12.84%
10,898,246 $1.98 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $16 Million - $18 Million
116,317 Added 1.22%
9,657,812 $1.5 Billion
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $158 Million - $183 Million
-1,181,766 Reduced 11.02%
9,541,495 $1.42 Billion
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $367 Million - $457 Million
-2,771,475 Reduced 20.54%
10,723,261 $1.44 Billion
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $294 Million - $338 Million
-2,029,836 Reduced 13.07%
13,494,736 $2.15 Billion
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $94 Million - $113 Million
-679,274 Reduced 4.19%
15,524,572 $2.51 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $10.1 Million - $11.6 Million
-75,444 Reduced 0.46%
16,203,846 $2.17 Billion
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $117 Million - $149 Million
-852,827 Reduced 4.98%
16,279,290 $2.49 Billion
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $309 Million - $384 Million
2,343,546 Added 15.85%
17,132,117 $2.78 Billion
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $178 Million - $225 Million
-1,658,755 Reduced 10.09%
14,788,571 $2 Billion
Q3 2021

Nov 16, 2021

SELL
$106.4 - $120.78 $147 Million - $167 Million
-1,381,568 Reduced 7.75%
16,447,326 $1.77 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $62.5 Million - $69.6 Million
-593,678 Reduced 3.22%
17,828,894 $2.01 Billion
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $9.24 Million - $10.2 Million
90,294 Added 0.49%
18,422,572 $1.99 Billion
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $110 Million - $148 Million
1,363,299 Added 8.03%
18,332,278 $1.96 Billion
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $49.9 Million - $58.5 Million
580,398 Added 3.54%
16,968,979 $1.49 Billion
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $358 Million - $478 Million
4,872,892 Added 42.32%
16,388,581 $1.61 Billion
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $336 Million - $509 Million
5,208,549 Added 82.58%
11,515,689 $877 Million
Q4 2019

Feb 18, 2020

BUY
$72.13 - $90.25 $184 Million - $231 Million
2,554,873 Added 68.09%
6,307,140 $558 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $322 Million - $387 Million
-5,105,308 Reduced 57.64%
3,752,267 $284 Million
Q2 2019

Jul 31, 2019

SELL
$65.7 - $83.98 $75.6 Million - $96.6 Million
-1,150,059 Reduced 11.49%
8,857,575 $644 Million
Q1 2019

Apr 30, 2019

BUY
$77.14 - $90.79 $68.4 Million - $80.6 Million
887,231 Added 9.73%
10,007,634 $807 Million
Q4 2018

Feb 06, 2019

BUY
$77.85 - $96.01 $324 Million - $400 Million
4,163,872 Added 84.01%
9,120,403 $841 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $25.6 Million - $28.4 Million
-287,425 Reduced 5.48%
4,956,531 $469 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $64.4 Million - $76.2 Million
717,452 Added 15.85%
5,243,956 $486 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $213 Million - $285 Million
2,312,173 Added 104.42%
4,526,504 $428 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $33.2 Million - $36.4 Million
370,647 Added 20.1%
2,214,331 $214 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $139 Million - $178 Million
-1,989,851 Reduced 51.91%
1,843,684 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,833,535
3,833,535 $278 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.